New targets uncovered at AACR 

The collection of new molecular targets proposed each year at AACR can serve as an early indicator of where oncology translation is headed. Spanning cancer types, therapeutic modalities and mechanisms, these targets point to emerging research priorities and future directions for drug development.

At this year’s American Association for Cancer Research (AACR) annual meeting, BioCentury identified 172 new molecular targets in the conference abstracts...